Endovascular Info

Carotid Artery Disease

Your brain is a very active organ. It is the control centre of your body. To work well, your brain needs a constant supply of oxygen and other nutrients found in your blood. Most of the blood flow to your brain comes from the carotid arteries which are large blood vessels on either side of your neck. The common carotid arteries (CCA), located on both sides of your neck, divide into two vessels. These vessels are called the external carotid arteries (ECA) and the internal carotid arteries (ICA).

What is Carotid Artery Disease?

Carotid artery disease is a condition that occurs when the arteries that supply oxygen-rich blood to the brain become narrowed or blocked. Usually this narrowing is caused by a build-up of “plaque.” Plaque is made up of fatty deposits (cholesterol), white blood cells, calcium, and other substances that collect over time in the wall of a carotid artery. This process is called “atherosclerosis.”

RX Acculink Carotid Stent System

The Xact Carotid Stent System (Xact), used in conjunction with the Emboshield Embolic Protection System is indicated for the improvement of the lumen diameter of carotid arteries in patients considered at high risk for adverse events from carotid endarterectomy who require percutaneous carotid angioplasty and stenting for occlusive artery disease.

More about RX Acculink Carotid Stent System

RX Accunet – Designed for Optimal Capture Efficiency

The Accunet Embolic Protection Device (EPS) is comprised of a delivery system and two recovery catheters with different features to address varying patient anatomies and clinical challenges. The RX Accunet EPS is indicated for use in patients undergoing percutaneous interventional procedures in carotid arteries to facilitate the placement of diagnostic and therapeutic devices during percutaneous interventional procedures, and capture and remove embolic material that may be released during the procedure.

More about RX Accunet Embolic Protection Device (EPS)

The Xact RX Carotid Stent System

used in conjunction with embolic protection system is indicated for the improvement of the lumen diameter of carotid arteries in patients considered at high risk for carotid Endarterectomy, but requiring percutaneous carotid angioplasty and stenting for occlusive carotid artery disease.

More about Xact RX Carotid Stent System

Emboshield Nav6 Embolic Protection System

Enables initial crossing with only a guide wire; it also allows the wire to move independent of the filter to ensure continued access to the index artery. The Emboshield NAV6 Embolic Protection System is designed to reduce distal embolization while maintaining blood flow during angioplasty and stent procedures. The system is indicated for use during percutaneous transluminal angioplasty and stenting procedures in saphenous vein grafts and carotid arteries.

More about Emboshield Nav6 Embolic Protection System

Renal Artery Stenosis

Renal artery stenosis is a narrowing of arteries that carry blood to one or both of the kidneys. Most often seen in older people with atherosclerosis (hardening of the arteries), renal artery stenosis can worsen over time and often leads to hypertension (high blood pressure) and kidney damage. The body senses less blood reaching the kidneys and misinterprets that as the body having low blood pressure. This signals the release of hormones from the kidney that lead to an increase in blood pressure. Over time, renal artery stenosis can lead to kidney failure.

The RX Herculink Elite Peripheral Stent System

Is intended to open lumen restrictions in the biliary tree, renal arteries, and protected peripheral arteries. Building on the proven deliverability of RX Herculink, using the advanced metallurgy of cobalt chromium. RX Herculink Elite sets new standards in renal stenting: Excellent radiopacity, low profile, high radial strength and superb stent flexibility.

More about RX Herculink Elite Peripheral Stent System

Viatrac 14 Plus PTA Balloon Catheter

The RX Viatrac 14 Plus peripheral Dilatation Catheter is intended to dilate stenosis in the peripheral arteries (iliac, femoral, ilio-femoral, popliteal, infra-popliteal, renal arteries). For the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

More about Viatrac 14 Plus PTA Balloon Catheter

Iliac Artery Stenosis

The common iliac artery originates from the abdominal aorta, the main blood vessel in the abdominal area. Both the aorta and the systemic arteries are part of the systemic circulatory system, which carries oxygenated blood from the heart to the other areas of the body and back.

The aorta ends at the fourth vertebra of the lumbar spine. There it divides into the right and left common iliac arteries. These two arteries travel down and to each side of the body for about five centimetres towards the edges of the pelvis. They then each split again into internal and external iliac arteries at the pelvic inlet, the area where the abdomen ends and the pelvis begins.

The internal iliac artery provides blood to the pelvic organs including the urinary bladder, the man’s prostate gland, and the woman’s uterus and vagina. The external iliac artery provides the main blood supply to the leg. It becomes the femoral artery and branches off as the popliteal artery and the anterior and posterior tibial arteries. The femoral artery supplies blood to the thigh, the popliteal artery supplies the knee area, and the anterior and posterior tibial arteries supply the area below the knee, including the feet and toes.

The common iliac artery is a paired structure, meaning there is one on the right and one on the left of the body.

Iliac artery disease is caused by the narrowing of these arteries (stenosis).

When not treated, it may cause pain in the lower leg when exercising or walking. In severe cases if no treatment is received it may lead to tissue loss.

Omnilink Elite Peripheral Stent System

With the proven MULTI-LINK stent design and CoCr material, this provides excellent deliverability, strength, and visibility with thinner struts. Making Omnilink Elite the only 6F sheath compatible balloon expandable stent system across all sizes.

More about Omnilink Elite Peripheral Stent System

Armada 35, Armada 35 LL PTA Balloon Catheter

Is intended for dilatation of lesions in the renal, iliac, femoral, popliteal, tibial and peroneal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The 4.0 to 10.0 mm balloon diameters are also indicated for post-dilatation of balloon expandable stents up to 100 mm and the 3.0 to 10.0 mm balloon diameters are also indicated for post-dilatation of self-expandable stents up to 250 mm in the vessels listed above.

More about Armada 35, Armada 35 LL PTA Balloon Catheter

SFA (Superficial Femoral Artery) Stenosis

The femoral artery is a large artery in the thigh and the main arterial supply to the lower limb. It enters the thigh from behind the inguinal ligament as the common femoral artery, a continuation of the external iliac artery. Here, it lies midway between the anterior superior iliac spine and the symphysis pubis. The common femoral artery gives off the profunda femoris artery and becomes the superficial femoral artery to descend along the anteromedial part of the thigh in the femoral triangle. It enters and passes through the adductor (subsartorial) canal, and becomes the popliteal artery as it passes through an opening in adductor magnus near the junction of the middle and distal thirds of the thigh.
This pain usually occurs distal to the arterial narrowing or obstruction. Since the superficial femoral and popliteal arteries are the vessels most commonly affected by the atherosclerotic process, the pain of intermittent claudication is most often localized to the calf.

This pain usually occurs distal to the arterial narrowing or obstruction. Since the superficial femoral and popliteal arteries are the vessels most commonly affected by the atherosclerotic process, the pain of intermittent claudication is most often localized to the calf.

Absolute Pro & Absolute Pro Long Length (LL) Self Expanding Stent

Is intended for the stenting of peripheral arteries as an adjunct to percutaneous transluminal angioplasty (PTA) and for the palliation of malignant strictures in the biliary tree.

More about Absolute Pro & Absolute Pro Long Length (LL) Self Expanding Stent

Armada 35, Armada 35 LL PTA Balloon Catheter

Is intended for dilatation of lesions in the renal, iliac, femoral, popliteal, tibial and peroneal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The 4.0 to 10.0 mm balloon diameters are also indicated for post-dilatation of balloon expandable stents up to 100 mm and the 3.0 to 10.0 mm balloon diameters are also indicated for post-dilatation of self-expandable stents up to 250 mm in the vessels listed above.

More about Armada 35, Armada 35 LL PTA Balloon Catheter

SUPERA VASCULAR MIMETIC STENT

Is a Novel Class of SFA Technology – Vascular Mimetic Technology Supera® is an effective option for the dynamic environment of the SFA and proximal popliteal as it mimics the natural structure and movement of the anatomy whilst maintaining strength and flexibility despite vessel deformation.

More about Supera Vascular Mimetic Stent

ARMADA 18 Balloon Dilatation Catheter

Armada 18 is indicated to dilate stenosis in femoral, popliteal, infra-popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. In addition, the device is also indicated for post-dilatation of balloon expandable and self-expanding stents.

More about ARMADA 18 Balloon Dilatation Catheter

BTK (Below The Knee) Artery Stenosis

Occlusive disease affecting the below-the-knee (BTK) arteries is a common and often serious manifestation of atherosclerosis. It tends to carry a number of significant implications, but causing claudication (in the absence of more proximal disease) is not one of them! So here’s the first important message: claudication is not an appropriate indication for treatment of BTK disease alone. Critical limb ischemia is the only acceptable indication for intervention in this setting.

The ARMADA 14 BALLOON DILATATION CATHETER

Is indicated to dilate stenosis in femoral, popliteal, infra popliteal and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also indicated for post-dilatation of balloon-expandable and self-expanding stents in the vessels listed above.

More about Armada 14 Balloon Dilatation Catheter

The Xpert Pro stent – Engineered to lead the way in BTK

Is indicated to dilate stenosis in femoral, popliteal, infra popliteal and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also indicated for post-dilatation of balloon-expandable and self-expanding stents in the vessels listed above.

More about The Xpert Pro stent

The XIENCE DRUG ELUTING STENT

Is clinically proven to improve luminal diameter in below the knee arteries.

More about The Xience Drug Eluting Stent

Varicose Veins

Fibrovein™

Fibrovein™ is a sclerosant used for the treatment of varicose veins. It is a sterile aqueous injection of Sodium Tetradecyl Sulfate (STS), an anionic detergent. It has been used in the treatment of varicose veins since 1946.

FIBROVEIN 3% (S1) H621 (ACT 101/1965), is currently the only strength registered by the Medicines Control Council.
South African Registered Indication: The solution is designed for intravenous use and is used primarily as a sclerosant in the treatment of varicose veins of the leg by compression sclerotherapy.

More about Fibrovein™

Elutax SV

3rd generation Drug Eluting Balloon (DEB)

The concept of drug-eluting balloons is based on the local delivery of drugs inside the vessel wall, thus achieving an effective and sufficient local concentration and avoiding systemic exposure to the drug.
Advantages of this technology are the possibility of uniformed drug transfer as compared to stent mediated drug release, in which the drug is only delivered at the contact site of the stent struts with the vessel wall
The absence of metal struts makes the technique suitable for treating long lesions, especially in small-diameter vessels and areas in which flexion and compression may occur.
The absence of a stent allows the artery’s original anatomy to remain intact, which is especially important in lesions at the level of a bifurcation.
Most of the currently available drug-eluting balloons use paclitaxel a cytotoxic and cytostatic agent.
Paclitaxel is naturally produced by the “Taxus brevifolia” plant. Recently, it can be also produced synthetically or semi-synthetically.
Paclitaxel is used as an anti-proliferative agent for the prevention of restenosis; locally delivered to the wall of the arteries, a paclitaxel coating inhibits various cell functions, e.g. the growth of neointima (scar tissue).

Elutax SV

Elutax SV is a three layer drug eluting balloon, with three different functions.

The ICE layer: The Ice layer fixes the paclitaxel on the balloon. Paclitaxel is connected to the Nylon balloon surface. Therefor it is possible to coat the balloon 360 degrees and the drug stays fixed on the balloon.
The Snow Layer: The Snow layer consists of the drug depot. The Snow Layer is formed of very small Paclitaxel crystals, which due to the size and the lipophilic properties can penetrate the vessel wall.
The Seal Layer: The Seal layer is a special lacquer coating which has two functions (a dry function and a wet function.)
While Dry it protects the paclitaxel from any mechanically interference.
While Wet it is transforming into a hydrogel coating, which allows the balloon to glide better in the vessel wall. Once the paclitaxel is detached from the balloon (at 6 atm) the Hydrogel absorbs the paclitaxel and control its uptake into the vessel wall.

Indications :

  • Peripheral lesions
  • Small vessels e.g. below the knee vessels
  • Femoral artery
  • Renal artery
  • In-stent restenosis
  • Dialysis AV fistulas (High Pressure)
  • Bifurcation lesions
More about Elutax SV

Peripheral Guide Wires

VESSEL CLOSURE

Perclose ProGlide®

For Hemostasis management one would look to achieve vessel healing parallel to the surgical gold standard. This would associate with significantly less blood transfusions, infections, mortality and shorter length of stay compared to surgical cutdown and a minimum intravascular footprint. A suitable device would promote vessel healing, with minimum inflammation and no re-access restrictions after use. This should give in-lab confidence, low access site complications, reduce time to hemostasis, ambulation, and discharge.

Perclose ProGlide Suture-Mediated Closure System. This product line offers vascular surgeons, interventional cardiologists and other healthcare providers an alternative to manual compression or sealing access sites on patients who have undergone a catheterization procedure.

Perclose ProGlide® provides percutaneous surgical repair with a suture by delivering a secure, non-masking percutaneous repair. Perclose ProGlide promotes primary intention healing with less scarring, and reduces time to hemostasis, ambulation and discharge.

More about Perclose ProGlide®